Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Clinical Nuclear Medicine|July 1, 2022
Incremental Value of 18 F-FDG-Labeled Leukocytes PET/CT Over 18 F-FDG PET/CT Scan in the Detection of Occult InfectionDivya Manda, Parul Thakral, Ishita Sen, et al.Clinical Nuclear Medicine|September 15, 2021
Upfront Use of 177Lu-Labeled PSMA Radioligand Therapy and Treatment Response Assessment in Treatment-Naive Prostate CancerDharmender Malik, Ishita B Sen, Parul Thakral, et al.Clinical Nuclear Medicine|March 27, 2024
Charting the Course of Targeted α Therapy With First-in-Human, Postadministration Image-Guided Dosimetry and Response Assessment of 212 Pb-VMT-α-NET in Metastatic Neuroendocrine TumorsNavneet Singh, Nishant Rana, Parul Thakral, et al.Cancer Biotherapy & Radiopharmaceuticals|June 28, 2022
Feasibility of 18F-FDG Labelling of Leucocytes in a Centre Without an On-Site Cyclotron and Monitoring of Radiation Dose to Occupational Worker in the Labelling ProcedureParul Thakral, Divya Manda, Subha Shankar Das, et al.Annals of Nuclear Medicine|June 1, 2021
Therapeutic efficacy of 225Ac-PSMA-617 targeted alpha therapy in patients of metastatic castrate resistant prostate cancer after taxane-based chemotherapyIshita Sen, Parul Thakral, Priya Tiwari, et al.Cancer Biotherapy & Radiopharmaceuticals|April 24, 2023
Validation of In-House Kit-Like Synthesis of 68Ga-Trivehexin and Its Biodistribution for Targeting the Integrin αvβ6 Expressing TumorsParul Thakral, Subha Shankar Das, Shweta Dhiman, et al.Cancer Biotherapy & Radiopharmaceuticals|November 7, 2024
Validation of Radiosynthesis and First in-Human Dosimetry of 68Ga-NOTA-UBI-29-41: A Proof of Concept StudyParul Thakral, Nishant Rana, Navneet Singh, et al.Journal of Nuclear Medicine Technology|October 13, 2019
Radiation Exposure to the Nuclear Medicine Personnel During Preparation and Handling of 213Bi-RadiopharmaceuticalsParul Thakral, Ishita Sen, Jakub Simecek, et al.Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|July 11, 2024
Lead-203 VMT-α-Neuroendocrine Tumor Scintigraphy: A Promising Theranostics AgentParul Thakral, Ishita Barat Sen, Subha Shankar Das, et al.Cancer Biotherapy & Radiopharmaceuticals|May 27, 2026
Validation of Manual In-House Synthesis, Imaging, Biodistribution, and Dosimetry of Tb-161 PSMA-617 for mCRPC Patients in a Tertiary Health Care Center: A Proof-of-Concept StudyParul Thakral, Nishant Rana, Abhishek Uppal, et al.Pageof 3